○Akihiko Shimomura1, Hiroshi Ohtsu2,3, Chikako Shimizu1, Shintaro Iwata4, Tatsuya Suzuki5, Kazuhiro Sase2 (1.Department of Breast and Medical Oncology, National Center for Global Health and Medicine, 2.Clinical Pharmacology and Regulatory Science, Juntendo University Graduate School of Medicine, 3.Department of Data Science, Center for Clinical Sciences, National Center for Global Health and Medicine, 4.Department of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, 5.Department of Hematology, National Cancer Center Hospital)
Session information
Oral Session
[O4] Oral Session 4 Patient Advocacy / Survivorship
Thu. Feb 17, 2022 1:20 PM - 2:50 PM Room 9 (Swan, 1F, Kyoto International Conference Center)
Chair:Keisuke Aoe(Department of Medical Oncology, National Hospital Organization Yamaguchi-Ube Medical Center),Nagio Takigawa(Department of General Internal Medicine 4, Kawasaki Medical School)
Discussant:Akira Inoue(Department of Palliative Medicine, Tohoku University School of Medicine)
○Yuko Osugi1, Miwa Ozawa2, Akiko Higuchi3, Haruka Ono4, Chikako Shimizu5, Keizo Horibe6 (1.Department of Hematology, Hyogo College of Medicine Hospital, 2.Department of Pediatrics, St. Luke's International Hospital, 3.Children’s Cancer Association of Japan, 4.Kusakabe Memorial Hospital, 5.Department of Breast and Medical Oncology, National Center for Global Health and Medicine, 6.Department of Pediatrics, National Hospital Organization Nagoya Medical Center)
○Hidetaka Uramoto1, Tomonobu Koizumi2, Azusa Tanimoto3, Ryuji Hayashi4, Ken-Ichi Ito5, Yasuo Hirono6, Seiji Yano3 (1.Department of Thoracic Surgery, Kanazawa Medical University, 2.Department of Comprehensive Cancer Therapy, Shinshu University School of Medicine, Matsumoto,, 3.Division of Medical Oncology, Cancer Research Institute, Kanazawa University,, 4.Department of Clinical Oncology, Toyama University Hospital, 5.Division of Breast and Endocrine Surgery, Department of Surgery, Shinshu University School of Medicine, 6.Cancer Care Promotion Center, University of Fukui Hospital)
○Yosuke Aoyama1, Yuichiro Kikawa2, Akihiko Shimomura3, Juhee Cho4, Hitomi Sato1, Kiyomi Nonogaki1, Koichiro Yoshino1, Taro Yamanaka1, Rika Kizawa1, Takeshi Yamaguchi1, Michiko Kurikawa5, Kiyo Tanaka5, Yoko Kobayashi5, Nobuko Tamura5, Yuko Tanabe1, Eri Hoshino6, Kojiro Shimozuma7, Koichi Suyama1, Yuji Miura1, Hidetaka Kawabata5 (1.Department of Medical Oncology, Toranomon Hospital, 2.Department of Breast Surgery, Kansai Medical University Hospital, 3.Department of Breast and Medical Oncology, National Center for Global Health and Medicine, 4.Department of Clinical Research Design and Evaluation SAIHST, Sungkyunkwan University, Seoul, Republic of South Korea, 5.Department of Breast and Endocrine Surgery, Toranomon Hospital, 6.Comprehensive Unit for Health Economic Evidence Review and Decision Support (CHEERS), Research Organization of Science and Technology, Ritsumeikan University, 7.Department of Biomedical Sciences, College of Life Sciences, Ritsumeikan University)
○Mikiko Sato1, Nao Suzuki2, Hitomi Sakai3, Yoshio Itani4, Shinya Sato5, Masayuki Futagami6, Yoshio Yoshida7 (1.Department of Obstetrics and Gynecology, Nihon University, 2.Department of Obstetrics and Gynecology, St. Marianna University School of Medicine, 3.dvanced Cancer Translational Research Institute (ACT), Showa University, 4.Yao Municipal Hospital Palliative Care Center, 5.Department of Obstetrics and Gynecology, Faculty of Medicine, Tottori University, 6.Department of Obstetrics and Gynecology, Hirosaki University Graduate School of Medicine, 7.Department of Obstetrics and Gynecology, Faculty of Medical Sciences, University of Fukui)
○Takashi Chinen (Department of Clinical Oncology, Jichi Medical University)